$1.02
0.00% yesterday
NYSE, Sep 12, 10:09 pm CET
ISIN
US35168W1036
Symbol
GUTS

Fractyl Health Stock price

$1.02
+0.04 3.67% 1M
-0.34 24.72% 6M
-1.04 50.49% YTD
-1.84 64.34% 1Y
-13.98 93.20% 3Y
-13.98 93.20% 5Y
-13.98 93.20% 10Y
-13.98 93.20% 20Y
NYSE, Closing price Fri, Sep 12 2025
+0.00 0.00%
ISIN
US35168W1036
Symbol
GUTS

Key metrics

Basic
Market capitalization
$73.6m
Enterprise Value
$81.3m
Net debt
$7.7m
Cash
$22.3m
Shares outstanding
49.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3,681.9 | -
EV/Sales
4,066.4 | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
26.3%
Return on Equity
-247.8%
ROCE
-248.5%
ROIC
-
Debt/Equity
-1.6
Financials (TTM | estimate)
Revenue
$20.0k | $0.0
EBITDA
$-98.9m | $-88.5m
EBIT
$-99.8m | $-99.4m
Net Income
$-99.8m | $-85.0m
Free Cash Flow
$-82.3m
Growth (TTM | estimate)
Revenue
-83.3% | -100.0%
EBITDA
-39.2% | 4.7%
EBIT
-39.9% | -6.2%
Net Income
-51.4% | -20.7%
Free Cash Flow
-53.4%
Margin (TTM | estimate)
Gross
58.8%
EBITDA
-581,470.6% | -
EBIT
-587,305.9%
Net
-586,864.7% | -
Free Cash Flow
-484,370.6%
More
EPS
$-2.1
FCF per Share
$-1.6
Short interest
4.9%
Employees
103
Rev per Employee
$0.0
Show more

Is Fractyl Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Fractyl Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Fractyl Health forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Fractyl Health forecast:

Buy
89%
Hold
11%

Financial data from Fractyl Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
0.02 0.02
83% 83%
100%
- Direct Costs 0.01 0.01
86% 86%
50%
0.01 0.01
80% 80%
50%
- Selling and Administrative Expenses 20 20
3% 3%
99,900%
- Research and Development Expense 80 80
57% 57%
399,350%
-99 -99
39% 39%
-494,250%
- Depreciation and Amortization 0.99 0.99
168% 168%
4,950%
EBIT (Operating Income) EBIT -100 -100
40% 40%
-499,210%
Net Profit -100 -100
51% 51%
-498,850%

In millions USD.

Don't miss a Thing! We will send you all news about Fractyl Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fractyl Health Stock News

Positive
Seeking Alpha
8 days ago
Fractyl Health's Revita offers a one-time procedure to maintain GLP-1 weight loss, with pivotal 45-patient trial data expected imminently. Early open-label results show Revita may significantly reduce post-GLP-1 weight regain. Despite past "OK" results in T2D, Revita's may have found its killer application in GLP-1 discontinuation patient; awarded FDA Breakthrough Device Designation.
Neutral
GlobeNewsWire
10 days ago
Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors Appointments include Christopher Thompson, M.D. and Ian Sheffield as Independent Directors
Neutral
Seeking Alpha
about one month ago
Fractyl Health, Inc. (NASDAQ:GUTS ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Brian Luque - Corporate Participant Harith Rajagopalan - Co-Founder, CEO & Director Lisa A. Davidson - CFO & Treasurer Conference Call Participants Jason Matthew Gerberry - BofA Securities, Research Division Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division W...
More Fractyl Health News

Company Profile

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Head office United States
CEO Harith Rajagopalan
Employees 103
Founded 2010
Website www.fractyl.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today